Skip to contentREED JOHN C — JOHNSON & JOHNSON insider: 77 transactions · InsiderLensREED JOHN C
- Director at PHARMION CORP · on record since Jun 12, 2006
- Director at STRATAGENE CORP · on record since Jun 5, 2006
- EVP, Innovative Medicine, R&D at JOHNSON & JOHNSON · on record since Apr 13, 2023
- Director at ISIS PHARMACEUTICALS INC · on record since Jul 5, 2006
- Director at ZONAGEN INC · on record since Oct 8, 2008
- Director at Clovis Oncology, Inc. · on record since Nov 15, 2011
- Regional VP - Northeast at COMMAND SECURITY CORP · on record since Jul 25, 2012
Insider trading activity of REED JOHN C
- Transactions on record
- 77
- since Jun 16, 2004
- Open-market buys
- 2
- $187.5K
- Open-market sells
- 9
- $20.8M
- Companies traded
- 7
- last filing May 4, 2026
Figures computed from official regulatory filings — methodology.
Companies where REED JOHN C has traded
Track record of REED JOHN C
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of REED JOHN C
Co-insiders of REED JOHN C
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
MAHAFFY PATRICK JClovis Oncology, Inc. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| May 4, 2026 | Other | -11,002 | 229.85 USD | $2.5M | SEC |
| May 4, 2026 | Exercise | 25,255 | 0.00 USD | $0 | SEC |
| May 4, 2026 | ExerciseD | -25,255 | 0.00 USD | $0 | SEC |
| Feb 18, 2026 | ExerciseD | -29,927 | 0.00 USD | $0 | SEC |
| Feb 18, 2026 | ExerciseD | -1,847 | 0.00 USD | $0 | SEC |
| Feb 18, 2026 | ExerciseD | -1,349 | 0.00 USD | $0 | SEC |
| Feb 18, 2026 | Exercise | 29,927 | 156.15 USD | $4.7M | SEC |
| Feb 18, 2026 | ExerciseD | -21,721 | 0.00 USD | $0 | SEC |
| Feb 18, 2026 | AwardD | 3,546 | 0.00 USD | $0 | SEC |
| Feb 18, 2026 | Exercise | 1,349 | 0.00 USD | $0 | SEC |
| Feb 18, 2026 | Sell | -21,721 | 243.00 USD | $5.3M | SEC |
| Feb 18, 2026 | Other | -528 | 243.45 USD | $128.5K | SEC |
| Feb 18, 2026 | AwardD | 49,382 | 0.00 USD | $0 | SEC |
| Feb 18, 2026 | Exercise | 21,721 | 157.92 USD | $3.4M | SEC |
| Feb 18, 2026 | Sell | -29,927 | 243.00 USD | $7.3M | SEC |
| Feb 18, 2026 | Other | -385 | 243.45 USD | $93.7K | SEC |
| Feb 18, 2026 | Exercise | 1,847 | 0.00 USD | $0 | SEC |
| Feb 18, 2026 | Sell | -2,283 | 243.00 USD | $554.8K | SEC |
| Oct 20, 2025 | Sell | -21,721 | 192.71 USD | $4.2M | SEC |
| Oct 20, 2025 | Exercise | 21,721 | 157.92 USD | $3.4M | SEC |
| Oct 20, 2025 | ExerciseD | -21,721 | 157.92 USD | $3.4M | SEC |
| Jul 18, 2025 | Sell | -19,137 | 163.55 USD | $3.1M | SEC |
| May 5, 2025 | ExerciseD | -25,255 | 0.00 USD | $0 | SEC |
| May 5, 2025 | Exercise | 25,255 | 0.00 USD | $0 | SEC |
| May 5, 2025 | Other | -11,002 | 156.31 USD | $1.7M | SEC |